FSCT is a non-surgical procedure using stem cells from healthy hair follicles to promote hair growth. It is compared to PRP and is offered by a clinic in India.
2% fucoidan alleviated AGA symptoms, promoted hair growth, and increased hair density in mice. Fucoidan is considered safe for humans as a supplement and topical skincare product, with potential therapeutic effects against AGA.
Fecal microbiota transplants (FMT) are discussed as a potential treatment for hair loss, but they are not effective for androgenic alopecia. The conversation also mentions that FMT is FDA-approved for recurrent C. diff infections and is being explored for other conditions.
A 25-year-old is discussing hair loss treatments, specifically FSCT, and mentions using Minoxidil, finasteride, and RU58841. They are seeking advice and experiences from others.
Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.
The conversation discusses the delay in bringing FAK inhibitors and Stanford's hydrogel to market for hair transplants, with a preference for FAK inhibitors over Verteporfin due to their superior potential in preventing scarring. The user expresses frustration over the slow progress and hopes for faster development by companies like FAKnostics.
The user underwent multiple hair transplants (FUT and FUE), used hair fibers, SMP, and eventually started finasteride and minoxidil to combat hair loss. Despite challenges and setbacks, they are satisfied with the current state of their hair and have learned to accept different looks, including a buzzcut with SMP.
The conversation is about comparing the effectiveness of fluridil and clascoterone in preventing hair loss and inquiring about their use as standalone treatments. There is a question about the concentration of the fluridil brand for efficacy.